This example dataset shows the findings associated with a cardiac magnetic resonance imaging procedure related to late gadolinium enhancement. There are different levels of granularity noted to show various tests and details that might be represented. The research requirements will determine what level of granularity is needed. For example, a study using LGE may require LGE test in their data without the detail of the analysis method, or the researchers may be interested if the assessment was done visually or with quantitative methods. If the study includes an assessment of each segment such as with the Segmental Late Gadolinium Enhancement Percentage, there may be interest in representing the quantitative analysis method of "Full-width half maximum" which is one of the types of analysis that may be done. The example provides how to represent this type of information if the researchers are interested in this type of information for the study data.
The Procedures (PR) domain represents diagnostic, preventive, and therapeutic activity. The example PR dataset shows the cardiac magnetic resonance imaging with two different MRI machines, using the SPDEVID to represent the imaging device identifier information provided in the DI dataset below.
The ANMETH variable describes the analysis method applied to obtain a summarized result. Analysis method describes the method of secondary processing applied to a complex observation result (e.g., an image, a genetic sequence) which in this case applies to the CMR imaging.
TO DO - Describe the analysis method for LGE - three different methods:
Full-width half maximum
5 standard deviations
6 standard deviations
Row 1:
Shows a cardiac MRI for participant 101.
Row 2:
Shows a cardiac MRI for participant 202 with a different MRI machine. The time of the procedure was not available so only the date is shown in the PRSTDTC variable.
pr.xpt
pr.xpt
Row
STUDYID
DOMAIN
USUBJID
SPDEVID
PRSEQ
PRREFID
PRLNKID
PRTRT
PRFAST
PRSTDTC
1
DMD-EFLGE
PR
101
ABC001
1
12345678
04
CARDIAC MAGNETIC RESONANCE IMAGING
Y
2023-07-01T09:15:00
2
DMD-EFLGE
PR
202
ABC002
1
98765432
05
CARDIAC MAGNETIC RESONANCE IMAGING
N
2023-07-05
$warningHtml
Dataset Wrapper Debug Message
Please add a row column to your dataset.
The Cardiovascular System Findings (CV) domain represents physiological and morphological findings related to the cardiovascular system, including the heart, blood vessels and lymphatic vessels. The findings from the CMR procedure for LGE are noted in this example. If LGE was not performed, it would not appear in the dataset.
Row 1:
Shows the late gadolinium enhancement (LGE) is positive for the overall Left Ventricle for participant 101.
Row 2:
Shows the late gadolinium enhancement (LGE) overall Left Ventricle percentage is 40% for participant 101.
Rows 3-18:
Show the segmental late gadolinium enhancement (LGE) values for each of the left ventricle segments for participant 101.
Row 19:
Shows the total late gadolinium enhancement (LGE) positive segments for participant 101.
Rows 20-23:
Show the segmental late gadolinium enhancement (LGE) percentage for each of the positive LGE segments for participant 101.
Row 24:
Shows the late gadolinium enhancement (LGE) is negative for participant 202.
cv.xpt
cv.xpt
Row
STUDYID
DOMAIN
USUBJID
CVSEQ
CVLNKID
CVTESTCD
CVTEST
CVORRES
CVORRESU
CVSTRESC
CVSTRESN
CVSTRESU
CVLOC
CVMETHOD
CVANMETH
VISITNUM
VISIT
CVDTC
1
DMD-EFLGE
CV
101
1
04
LGE
LATE GADOLINIUM ENHANCEMENT
POSITIVE
POSITIVE
LEFT VENTRICLE
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
2
DMD-EFLGE
CV
101
2
04
TLGEPR
TOTAL LATE GADOLINIUM ENHANCEMENT PERCENTAGE
40
%
40
40
%
LEFT VENTRICLE
CARDIAC MAGNETIC RESONANCE IMAGING
QUANTITATIVE
1
VISIT 1
2023-07-01
3
DMD-EFLGE
CV
101
3
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR BASAL ANTERIOR SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
4
DMD-EFLGE
CV
101
4
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
POSITIVE
POSITIVE
LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
5
DMD-EFLGE
CV
101
5
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
POSITIVE
POSITIVE
LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
6
DMD-EFLGE
CV
101
6
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR BASAL INFERIOR SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
7
DMD-EFLGE
CV
101
7
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
8
DMD-EFLGE
CV
101
8
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
9
DMD-EFLGE
CV
101
9
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR MID ANTERIOR SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
10
DMD-EFLGE
CV
101
10
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
POSITIVE
POSITIVE
LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
11
DMD-EFLGE
CV
101
11
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
POSITIVE
POSITIVE
LEFT VENTRICULAR INFEROSEPTAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
12
DMD-EFLGE
CV
101
12
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR MID INFERIOR SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
13
DMD-EFLGE
CV
101
13
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR MID INFEROLATERAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
14
DMD-EFLGE
CV
101
14
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
15
DMD-EFLGE
CV
101
15
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR APICAL ANTERIOR SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
16
DMD-EFLGE
CV
101
16
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR APICAL SEPTAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
17
DMD-EFLGE
CV
101
17
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR APICAL INFERIOR SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
18
DMD-EFLGE
CV
101
18
04
SGTLGE
SEGMENTAL LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICULAR APICAL LATERAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
19
DMD-EFLGE
CV
101
19
04
TLGE
TOTAL LGE SEGMENTS
4
4
4
LEFT VENTRICLE
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-01
20
DMD-EFLGE
CV
101
20
04
LGEPER
LATE GADOLINIUM ENHANCEMENT PERCENTAGE
40
%
40
40
%
LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
FULL-WIDTH HALF MAXIMUM
1
VISIT 1
2023-07-01
21
DMD-EFLGE
CV
101
21
04
LGEPER
LATE GADOLINIUM ENHANCEMENT PERCENTAGE
20
%
20
20
%
LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
FULL-WIDTH HALF MAXIMUM
1
VISIT 1
2023-07-01
22
DMD-EFLGE
CV
101
22
04
LGEPER
LATE GADOLINIUM ENHANCEMENT PERCENTAGE
45
%
45
45
%
LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
FULL-WIDTH HALF MAXIMUM
1
VISIT 1
2023-07-01
23
DMD-EFLGE
CV
101
23
04
LGEPER
LATE GADOLINIUM ENHANCEMENT PERCENTAGE
20
%
20
20
%
LEFT VENTRICULAR INFEROSEPTAL SEGMENT
CARDIAC MAGNETIC RESONANCE IMAGING
FULL-WIDTH HALF MAXIMUM
1
VISIT 1
2023-07-01
24
DMD-EFLGE
CV
202
1
04
LGE
LATE GADOLINIUM ENHANCEMENT
NEGATIVE
NEGATIVE
LEFT VENTRICLE
CARDIAC MAGNETIC RESONANCE IMAGING
VISUAL
1
VISIT 1
2023-07-05
$warningHtml
Dataset Wrapper Debug Message
Please add a row column to your dataset.
The Procedure Agent (AG) represents the agents administered to the participant as part of a procedure or assessment. The example AG dataset shows the timing of the gadolinium-based contrast, GD-DOTA. The time the contrast was given to participant 202 was not available, so only the date is represented in AGSTDTC variable.